If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Zepbound ® (tirzepatide) injection
2.5 mg/ 5 mg/ 7.5 mg/ 10 mg/ 12.5 mg/ 15 mg
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Is Zepbound® (tirzepatide) available as an oral formulation?
Tirzepatide is not available in pill form for oral administration. Tirzepatide is an injectable medicine for subcutaneous use.
Boxed Warning
See important safety information, including boxed warning, in the attached prescribing information.
Tirzepatide Formulation
Tirzepatide is not available in pill form for oral administration.1
Tirzepatide is an injectable medicine for subcutaneous use. It contains tirzepatide, a once weekly glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist.1
The molecular weight of tirzepatide is 4813.53 daltons.1 Generally, medicines with a molecular weight greater than 500 daltons are not absorbed orally.
Tirzepatide injection is a clear, colorless to slightly yellow, sterile solution.1
Enclosed Prescribing Information
Reference
1Zepbound [package insert]. Indianapolis, IN: Eli Lilly and Company; 2025.
Date of Last Review: September 23, 2025